Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Pursuing the ‘obvious ethical imperative’ of a dual-target strategy in RA Rob Volansky
-
- Healio Rheumatology and the lives of rheumatologists Leonard H. Calabrese, DO
- 'We need to see the data': FDA's Xeljanz safety warning stirs concerns for JAK inhibitors Jason Laday
- ACR: Vaccinate patients with musculoskeletal, inflammatory, autoimmune disease for COVID-19 Jason Laday
- Lobstering and RA: Why I pursued a fellowship in rheumatology Chuck Radis, DO
- Antimalarial adherence lowers risk for death by 83% in lupus Jason Laday
- Cardiovascular risk underestimated in women, younger patients with rheumatoid arthritis Jason Laday
- 'Checklist' may help distinguish overlapping features of COVID-19, giant cell arteritis Jason Laday
- 'Little justification' for antidepressants in back pain, may be effective in OA Jason Laday
-
- More than 200,000 people in US meet criteria for systemic lupus erythematosus Jason Laday
- Nail psoriasis in PsA linked to more severe symptoms, worse quality of life Jason Laday
- Patients with PsA respond better to biologic DMARDs vs. those with RA at 12 years Jason Laday
- COVID-19 delivers 'wake-up call' to raise activity levels for viral defense, immunity Rob Volansky
- Sleep disturbance bound to inflammation, immune response in 'feed forward loop' Rob Volansky
- COVID therapies needed beyond vaccine: Role of monoclonal antibodies, convalescent plasma? Jason Laday